Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2022 2
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
A new genome sequence resource for five invasive fruit flies of agricultural concern: Ceratitis capitata, C. quilicii, C. rosa, Zeugodacus cucurbitae and Bactrocera zonata (Diptera, Tephritidae).
Deschepper P, Vanbergen S, Esselens L, Terblanche JS, Karsten M, Snyman M, Cugala D, Canhanga L, Bota L, Mwatawala M, Ramadhani M, Kudra A, Tairo J, Bakengesa J, Addison P, Manrakhan A, Gledel C, Delatte H, De Meyer M, Virgilio M. Deschepper P, et al. Among authors: gledel c. F1000Res. 2024 Dec 6;13:1492. doi: 10.12688/f1000research.157946.1. eCollection 2024. F1000Res. 2024. PMID: 40028447 Free PMC article.
Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone in an Older Population: The PhASAge Study.
Roubaud-Baudron C, Fauchon H, Stanke-Labesque F, Paccalin M, Breilh D, Grégoire N, Forestier E, Ferry T, Gavazzi G, Goutelle S; Infectiology and Geriatrics InterGroup (SPILF-SFGG GInGer). Roubaud-Baudron C, et al. Open Forum Infect Dis. 2025 May 30;12(6):ofaf313. doi: 10.1093/ofid/ofaf313. eCollection 2025 Jun. Open Forum Infect Dis. 2025. PMID: 40567999 Free PMC article. Clinical Trial.
Preoperative and perioperative risk factors, and risk score development for prosthetic joint infection due to Staphylococcus aureus: a multinational matched case-control study.
Espindola R, Vella V, Benito N, Mur I, Tedeschi S, Rossi N, Hendriks JGE, Sorlí L, Murillo O, Scarborough M, Scarborough C, Kluytmans J, Ferrari MC, Pletz MW, Mcnamara I, Escudero-Sanchez R, Arvieux C, Batailler C, Dauchy FA, Liu WY, Lora-Tamayo J, Praena J, Ustianowski A, Cinconze E, Pellegrini M, Bagnoli F, Rodríguez-Baño J, Del Toro MD; ARTHR-IS group. Espindola R, et al. Clin Microbiol Infect. 2022 Oct;28(10):1359-1366. doi: 10.1016/j.cmi.2022.05.010. Epub 2022 May 18. Clin Microbiol Infect. 2022. PMID: 35597508 Free article.
Rates and Predictors of Treatment Failure in Staphylococcus aureus Prosthetic Joint Infections According to Different Management Strategies: A Multinational Cohort Study-The ARTHR-IS Study Group.
Espíndola R, Vella V, Benito N, Mur I, Tedeschi S, Zamparini E, Hendriks JGE, Sorlí L, Murillo O, Soldevila L, Scarborough M, Scarborough C, Kluytmans J, Ferrari MC, Pletz MW, Mcnamara I, Escudero-Sanchez R, Arvieux C, Batailler C, Dauchy FA, Liu WY, Lora-Tamayo J, Praena J, Ustianowski A, Cinconze E, Pellegrini M, Bagnoli F, Rodríguez-Baño J, Del Toro MD; ARTHR-IS Group. Espíndola R, et al. Infect Dis Ther. 2022 Dec;11(6):2177-2203. doi: 10.1007/s40121-022-00701-0. Epub 2022 Oct 15. Infect Dis Ther. 2022. PMID: 36242742 Free PMC article.
Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients.
Pradat P, Durant J, Brochier C, Trabaud MA, Cottalorda-Dufayard J, Izopet J, Raffi F, Lucht F, Gagnieu MC, Gatey C, Jacomet C, Vassallo M, Dellamonica P, Cotte L; No Nuc No Boost Study Group. Pradat P, et al. J Antimicrob Chemother. 2016 Nov;71(11):3235-3241. doi: 10.1093/jac/dkw273. Epub 2016 Jul 17. J Antimicrob Chemother. 2016. PMID: 27432606 Clinical Trial.